RCKT insider files notice to sell 3,493 shares

RCKT reporting person Martin Wilson filed a notice of proposed sale of common stock.

Rhea-AI Filing Summary

RCKT reporting person Martin Wilson filed a notice of proposed sale of common stock. The filing lists up to 3,493 common shares to be sold through Fidelity Brokerage Services LLC on or after 08/13/2026, following a restricted stock vesting event for 3,493 shares on 08/11/2026 as compensation. It also discloses prior sales of 3,361 shares for $12,118.42 on 05/13/2026 and 662 shares for $1,995.53 on 05/19/2026.

Key Figures

Shares proposed to be sold: 3,493 shares Aggregate amount for proposed sale line: $11,810.18 Prior sale 1 shares: 3,361 shares +4 more

7 metrics

Shares proposed to be sold 3,493 shares Common stock listed for sale through Fidelity Brokerage Services LLC

Aggregate amount for proposed sale line $11,810.18 Amount associated with 3,493 common shares in the sale notice

Prior sale 1 shares 3,361 shares Common stock sold on 05/13/2026 in the last 3 months

Prior sale 1 value $12,118.42 Aggregate amount for 3,361 shares sold on 05/13/2026

Prior sale 2 shares 662 shares Common stock sold on 05/19/2026 in the last 3 months

Prior sale 2 value $1,995.53 Aggregate amount for 662 shares sold on 05/19/2026

Restricted stock vesting shares 3,493 shares Shares vested as restricted stock on 08/11/2026 as compensation

Key Terms

Form 144, Restricted Stock Vesting, compensation

3 terms

Form 144 regulatory

"The Form 144 shows Martin Wilson plans to sell up to 3,493 RCKT shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"The 3,493 shares originated from a Restricted Stock Vesting event on 08/11/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

compensation financial

"The issuer granted these shares as compensation and they are now eligible to be sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for RCKT by Martin Wilson disclose?

The Form 144 shows Martin Wilson plans to sell up to 3,493 RCKT common shares through Fidelity Brokerage Services LLC, with the proposed sale date listed as 08/13/2026. It is a notice of potential, not guaranteed, sales.

How many RCKT shares are proposed to be sold under this Form 144?

The filing lists a proposed sale of 3,493 common shares of RCKT. These shares are to be sold through Fidelity Brokerage Services LLC, with NASDAQ indicated as the trading market and 08/13/2026 as the proposed sale date.

What is the origin of the 3,493 RCKT shares in the Form 144 filing?

The 3,493 shares originated from a Restricted Stock Vesting event on 08/11/2026. The filing states the issuer granted these shares as compensation, and they are now eligible to be sold under this notice.

What prior RCKT stock sales by Martin Wilson are reported in the last 3 months?

The filing reports two prior sales: 3,361 shares for $12,118.42 on 05/13/2026, and 662 shares for $1,995.53 on 05/19/2026. Both transactions involved RCKT common stock.

Where will the RCKT shares in this Form 144 filing be sold?

The proposed sale of 3,493 RCKT common shares is listed through Fidelity Brokerage Services LLC, with NASDAQ identified as the trading market. The proposed sale date recorded is 08/13/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 04:03 PM Accepted by SEC EDGAR 08/13/2026 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001704342
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ROCKET PHARMACEUTICALS, INC.
SEC File Number	001-36829
Address of Issuer	350 FIFTH AVENUE SUITE 7530 NEW YORK NEW YORK 10118
Phone	646-440-9100
Name of Person for Whose Account the Securities are To Be Sold	Wilson Martin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3493	11810.18	109774597	08/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/11/2026	Restricted Stock Vesting	Issuer			3493	08/11/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Martin Wilson 9 Cedarbrook Drive Cranbury NJ 08512	Common	05/13/2026	3361	12118.42
Martin Wilson 9 Cedarbrook Drive Cranbury NJ 08512	Common	05/19/2026	662	1995.53

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	08/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Martin Wilson.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)